Please Note - Streaming News is only available to subscribers to the Active Level and above
Director Deals - (GSK)
BFN
Hal Barron, Executive Director, has re-invested 990 shares in the company on the 14th January 2025 at a price of $16.88. The Director now holds 681,878 shares.
Story provided by StockMarketWire.com
Director deals data provided by www.sharesmagazine.co.uk
